Back to NBIX
Vestal Point Capital, LP → NBIX
Vestal Point Capital, LP NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
3
Latest value
$354.6M
Q3 2026
Peak value
$354.6M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $164.7M |
| Q2 2026 | $316.8M |
| Q3 2026 | $354.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $354.6M | 2.50M | — | — |
| Q2 2026 | $316.8M | 1.88M | — | — |
| Q1 2026 | $164.7M | 1.25M | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.2B
$1.1B
$1.1B
$997.5M
$992.8M